Aeterna Zentaris, Inc. (USA) (AEZS)

Brian7992 (< 20) Submitted: 8/11/2009 2:29:09 PM : Start Price: $2.70 AEZS Score: -72.76

Bio Beautiful

EddyG3 (< 20) Submitted: 7/21/2009 9:12:43 AM : Start Price: $1.78 AEZS Score: -58.77

Expecting positive phase 3 results for Cetrorelix sometime this Q

derwin24 (27.07) Submitted: 10/27/2007 5:12:33 AM : Start Price: $1.92 AEZS Score: -21.97

Short term: This stock is probable to Underperform. The Company provided updated guidance for the 2007 total expected burn in a range of $25-$27 million.

Long term: This will be a hot stock to own. Potential for base case peak annual sales of over $500 million in the United States market alone; lower sales could reach $200 million.

puntolyang (< 20) Submitted: 8/29/2007 4:09:41 PM : Start Price: $2.91 AEZS Score: -44.59

this company has outstanding leadership along with promising products in various phases. It also MAKES an income and has very good cash balance.

OneStarHero (< 20) Submitted: 6/4/2007 9:23:30 PM : Start Price: $3.71 AEZS Score: -48.13

This is a sure thing, chech this out:

AETERNA ZENTARIS

swap some letters around...

ZANIEST EARN RATE

biotechuk (< 20) Submitted: 3/28/2007 3:17:01 PM : Start Price: $3.90 AEZS Score: -55.82

undervalued with a strong pipeline.

YoungScientist63 (84.25) Submitted: 1/18/2007 6:10:42 PM : Start Price: $4.38 AEZS Score: +58.53

Uhhhh............ it will just do bad. :) --A Scientist

TechnicalTommy (41.14) Submitted: 1/17/2007 9:18:00 AM : Start Price: $4.40 AEZS Score: -58.46

short term recovery

codie040 (22.20) Submitted: 1/3/2007 12:14:09 PM : Start Price: $4.05 AEZS Score: -56.35

Small bio-tech with several drugs in pipeline ready for approval.

PlovieR (< 20) Submitted: 10/6/2006 7:38:21 PM : Start Price: $2.96 AEZS Score: -52.08

Undervalued.
2 Drugs on Market
2 in phase 3
5 in Phase 2

70 million in Cash